Trade Report: Today, Hemispherx BioPharma, Inc (HEB) Short Interest Down 21.2% in November

Today, Hemispherx BioPharma, Inc (HEB) Short Interest Down 21.2% in November

Hemispherx BioPharma, Inc (NYSE:HEB) was the target of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 135,027 shares, a drop of 21.2% from the October 31st total of 171,329 shares. Approximately 0.7% of the shares of the stock are short sold. Based on an average daily volume of 88,065 shares, the days-to-cover ratio is presently 1.5 days.

Shares of Hemispherx BioPharma (NYSE:HEB) opened at 0.85 on Friday. Hemispherx BioPharma has a 12 month low of $0.72 and a 12 month high of $2.64. The stock has a 50 day moving average of $0.97 and a 200 day moving average of $1.39. The firm’s market cap is $20.49 million.

Hemispherx BioPharma (NYSE:HEB) last issued its quarterly earnings data on Monday, November 14th. The specialty pharmaceutical company reported ($0.30) earnings per share for the quarter. During the same period last year, the firm posted ($0.62) EPS.

About Hemispherx BioPharma

Related posts

Leave a Comment